NVAX
NVAX
NASDAQ · Biotechnology

Novavax Inc

$9.13
-0.37 (-3.89%)
As of Jun 21, 10:09 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 2 13%
Sell 3 20%
Price Target
Analyst Price Target +216.3% upside
Low Target $20.35
Average Target $28.88
High Target $29.25
Current Price $9.13
Current
$9.13
Target
$28.88
$20.35 $28.88 avg $29.25
Scenario Analysis
Bear Case
$20.35
122.9%
Low target
Base Case
$28.88
+216.3%
Avg target
Bull Case
$29.25
+220.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$11.97
-23.7% from high
52-Week Low
$6.13
+48.9% from low
Target vs 52W High
$28.88
+141.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%